The prospect of orally administered monoclonal secretory IgA (SIgA) antibodies to prevent enteric bacterial infections
Eliminating diarrheal diseases as a leading cause of childhood morbidity and mortality in low- and middle-income countries (LMICs) will require multiple intervention strategies. In this review, we spotlight a series of preclinical studies investigating the potential of orally administered monoclonal...
Wedi'i Gadw mewn:
| Prif Awduron: | , , |
|---|---|
| Fformat: | Artigo |
| Iaith: | Inglês |
| Cyhoeddwyd: |
Taylor & Francis Group
2022-04-01
|
| Cyfres: | Human Vaccines & Immunotherapeutics |
| Pynciau: | |
| Mynediad Ar-lein: | http://dx.doi.org/10.1080/21645515.2021.1964317 |
| Tagiau: |
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!
|